...
首页> 外文期刊>Genes, Chromosomes and Cancer >The co‐regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer
【24h】

The co‐regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer

机译:结直肠癌中肿瘤抑制基因,癌肠和miRNA的共调控网络

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Tumor suppressor genes (TSGs) and oncogenes (OG) are involved in carcinogenesis. MiRNAs also contribute to cellular pathways leading to cancer. We use data from 217 colorectal cancer (CRC) cases to evaluate differences in TSGs and OGs expression between paired CRC and normal mucosa and evaluate how TSGs and OGs are associated with miRNAs. Gene expression data from RNA‐Seq and miRNA expression data from Agilent Human miRNA Microarray V19.0 were used. We focus on genes most strongly associated with CRC (fold change (FC) of ≥1.5 or ≤0.67) that were statistically significant after adjustment for multiple comparisons. Of the 74 TSGs evaluated, 22 were associated with carcinoma/normal mucosa differential expression. Ten TSGs were up‐regulated ( FAM123B, RB1, TP53, RUNX1, MSH2, BRCA1, BRCA2 , SOX9, NPM1 , and RNF43); six TSGs were down‐regulated ( PAX5, IZKF1, GATA3, PRDM1, TET2 , and CYLD) ; four were associated with MSI tumors ( MLH1, PTCH1, and CEBPA down‐regulated and MSH6 up‐regulated); and two were associated with MSS tumors ( PHF6 and ASXL1 up‐regulated). Thirteen of these TSGs were associated with 44 miRNAs. Twenty‐seven of the 59 OGs evaluated were dysregulated: 14 down‐regulated (KLF4, BCL2, SSETBP1, FGFR2, TSHR, MPL, KIT, PDGFRA, GNA11, GATA2, FGFR3, AR, CSF1R, and JAK3), seven up‐regulated (DNMT1, EZH2, PTPN11, SKP2, CCND1, MET, and MYC); three down‐regulated for MSI (FLT3, CARD11, and ALK); two up‐regulated for MSI (IDH2 and HRAS); and one up‐regulated with MSS tumors (CTNNB1). These findings suggest possible co‐regulatory function between TSGs, OGs, and miRNAs, involving both direct and indirect associations that operate through feedback and feedforward loops.
机译:摘要肿瘤抑制基因(TSG)和癌基因(OG)涉及致癌作用。 MiRNA也有助于导致癌症的细胞途径。我们使用来自217结肠直肠癌(CRC)病例的数据来评估CRC和正常粘膜之间TSG和OGS表达的差异,并评估TSG和OGS如何与MIRNA相关。使用来自Agilent人miRNA微阵列V19.0的RNA-SEQ和miRNA表达数据的基因表达数据。我们专注于与CRC(折叠变化(Fc)相关的基因(≥1.5或≤0.67),在调整多重比较后在统计学上显着。在评估的74stgs中,22例与癌/正常粘膜差异表达有关。上调十个TSG(FAM123B,RB1,TP53,RUNX1,MSH2,BRCA1,BRCA2,SOX9,NPM1和RNF43);六个TSG被调节(PAX5,IZKF1,GATA3,PRDM1,TET2和CYLD);四与MSI肿瘤(MLH1,PTCH1和CEBPA下调和MSH6上调)有关;两者与MSS肿瘤(PHF6和ASXL1上调)有关。这款TSG的十三个与44 miRNA有关。评估的59个OGS中的270-7种评价:14个下调(KLF4,BCL2,SSETB1,FGFR2,TSHR,MPL,试剂盒,PDGFRA,GNA11,GATA2,FGFR3,AR,CSF1R和JAK3),七个上调(DNMT1,EZH2,PTPN11,SKP2,CCND1,MET和MYC); MSI的三个下调(FLT3,CARD11和ALK);两个对MSI的上调(IDH2和HRA);并用MSS肿瘤(CTNNB1)上调一个上调。这些调查结果表明TSG,OGS和MIRNA之间可能的共同调节功能,涉及通过反馈和前馈环操作的直接和间接关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号